Sera
Develops blood tests and predictive analytics for earlier assessment of spontaneous preterm-birth risk.
$2.00
After-hours close−0.06 (−3.15%)
At close$2.07(+1.72%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.15 | −$0.18 | −16.7% |
| May 2026 | −$0.16 | −$0.17 | −6.3% |
| Mar 2026 | −$0.17 | −$0.16 | +5.9% |
| Nov 2025 | −$0.19 | −$0.16 | +15.8% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.14 | — | — | $75.0K | — | — |
| Aug 12, 2026 | −$0.15 | −$0.18 | −16.7% | $71.4K | $30.0K | −58.0% |
| May 6, 2026 | −$0.16 | −$0.17 | −6.3% | $66.7K | $14.0K | −79.0% |
| Mar 18, 2026 | −$0.17 | −$0.16 | +5.9% | $31.8K | $10.0K | −68.5% |
| Nov 13, 2025 | −$0.19 | −$0.16 | +15.8% | $50.4K | $16.0K | −68.2% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 19, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 20, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 10, 2023 | ||||||
| Mar 22, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 10, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 29, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 30, 2021 | ||||||
| Jul 16, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||